Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-22

Clinical Trial Update: Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pregabalin for chronic prostatitis/chronic pelvic pain syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) | Phase 3 | Status: COMPLETED | Results posted: 2025-09-22